Corneal Changes in Estrogen-Dependent Breast Cancer After Hormonal Treatment
NCT ID: NCT06924229
Last Updated: 2025-04-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
40 participants
INTERVENTIONAL
2024-06-01
2025-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Bimatoprost Gel on Eyelash Growth
NCT01200251
ALEXANDRIA Study Egypt
NCT03583463
Comparative Study for the Degree of Biological Changes After Short-term 2 Weeks and 4 Weeks Preoperative Endocrine Therapy in Luminal Breast Cancer
NCT04023292
Pre-Operative Window of Adjuvant Endocrine Therapy to Inform RT Decisions in Older Women With Early-Stage Breast Cancer
NCT04272801
Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer
NCT00002529
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This cross-sectional study was conducted on female patients aged ≥18 who received treatment for BC. Patients were evaluated by a number of tests to determine the effects on the cornea and the lacrimal system
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patients with breast cancer recieving hormonal treatment
evaluation of the effect of hormonal treatment on the cornea
Hormonal treatment
hormonal treatment for breast cancer
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hormonal treatment
hormonal treatment for breast cancer
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sohag University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Haitham Thabit
Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elshimaa abd almateen A mateen, Doctorate
Role: STUDY_CHAIR
Sohag University
alaa mahmoud m mahmoud
Role: STUDY_CHAIR
mahmoud
mohamed salah hamed s hamed, Doctorate
Role: STUDY_DIRECTOR
Sohag University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sohag university
Sohag, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
breast cancer therapy
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Soh-Med-24-03-14PD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.